Journal of Clinical Oncology, Vol 10, 1988, Copyright © 1992 by American Society of Clinical Oncology
Pharmacokinetics and Pharmacodynamics of Medroxyprogesterone Acetate in Advanced Breast Cancer Patients
M.C. Etienne ,
G. Milano ,
M. Frenay ,
N. Renee ,
E. Francois ,
A. Thyss ,
M. Schneider , ,
M. Namer
There were several production errors in the report by Etienne et al, "Pharmacokinetics and Pharmacodynamics of Medroxyprogesterone Acetate in Advanced Breast Cancer Patients," published in the July 1992 issue (J Clin Oncol 10:1176–1182, 1992). In the abstract (p 1176), the abbreviation "Css minutes" should have been "Css min" for minimum steady-state concentration. The P value for the second footnote to Table 2 (p 1178) should have been ".99." In the Discussion section, the fourth sentence of the second paragraph (p 1180) should have read: "As concerns the 70 patients who received 1,000 mg/d orally, MPA concentrations ranged from 10 to 269 ng/mL (Fig 1)."
